To make a difference, HIV prevention research and its results have to be understood by many stakeholders.
That’s why AVAC works to connect scientists and stakeholders through every stage of HIV prevention research and implementation—from identifying promising scientific questions for further study, through the design and conduct of clinical trials, to the rollout and marketing of proven technologies.
In addition to analysis and data focused on specific HIV prevention strategies, we provide and collate basic documents and key resources to help a range of stakeholders understand, analyze and act on research findings. These include:
Key Concepts of Clinical Trials
- Pharmacokinetics and Pharmacodynamics: A primer for HIV prevention advocates
- Adherence in HIV Prevention Research: A primer for HIV prevention advocates
- When do you stop an HIV prevention trial for futility? A primer for HIV prevention advocates
- Fact Sheet: Data Safety Monitoring Boards
- Advocates' Guide to Statistical Terms
- From Research to Rollout: Evaluations that move a product to the "real world"
Key Concepts of Research Ethics
- The Principles of Research Ethics
- Ethical Guidance Documents
- Research Ethics in Action
- Good Participatory Practice Initiative
- Communications Handbook for Clinical Trials
- Stakeholder Engagement Toolkit for HIV Prevention Trials
- ClinRegs — online database of country-specific clinical research regulatory information